1 citations
,
September 2022 in “Journal of The American Academy of Dermatology” Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.
2 citations
,
January 2022
2 citations
,
December 2004 in “Medicine” Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.
63 citations
,
April 2003 in “Journal of The European Academy of Dermatology and Venereology” Minoxidil use increases facial hair growth in females, more in older users.
26 citations
,
January 1994 in “McGraw-Hill eBooks” Many hair loss conditions can be treated.
58 citations
,
October 1993 in “International Journal of Dermatology” Minoxidil helps hair growth and reduces shedding in women.
11 citations
,
April 1990 in “Australasian Journal of Dermatology” Minoxidil modestly increases hair growth in men with early baldness and is safe to use.
11 citations
,
July 1988 in “International Journal of Dermatology” The study found that using 2% minoxidil solution can help grow hair and is safe.
8 citations
,
May 1987 in “Journal of The American Academy of Dermatology” UV light does not significantly affect minoxidil's ability to treat male pattern baldness.
26 citations
,
January 1987 in “Dermatology” A 48-week study conducted in France, West Germany, and the UK evaluated the efficacy and safety of 2% topical minoxidil for early male-pattern baldness. At week 24, 225 patients were assessed, with 116 in the treatment group and 109 in the placebo group. The minoxidil group showed significant improvements in non-vellus hair counts and hair growth evaluations compared to placebo, with no significant differences in blood pressure, pulse, or weight changes. Dermatological side effects were mild. From weeks 24 to 48, all patients received minoxidil, resulting in further hair growth, with 32.7% showing moderate or dense new hair growth by week 48. The study concluded that topical minoxidil was a safe and effective treatment for some patients with early male-pattern baldness, though further research was needed to identify likely responders.